[Progesterone receptor in breast cancer: fundamental data and clinical applications].
Ojasoo
T
T
Systèmes moléculaires et biologie structurale, Université Pierre et Marie-Curie VI, Paris, France.
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000378:metabolism*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis* / Q000096:biosynthesis / Q000235:genetics; D013629:Tamoxifen / Q000494:pharmacology / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen
Le récepteur de la progestérone dans les cancers du sein: données fondamentales et applications cliniques.